Roslindale, MA, United States of America

Lyne Breault

USPTO Granted Patents = 17 


 

Average Co-Inventor Count = 9.8

ph-index = 5

Forward Citations = 107(Granted Patents)


Company Filing History:


Years Active: 2010-2023

where 'Filed Patents' based on already Granted Patents

17 patents (USPTO):

Title: The Innovative Contributions of Lyne Breault

Introduction

Lyne Breault is a prominent inventor based in Roslindale, MA (US), known for her significant contributions to the field of biotechnology. With a total of 17 patents to her name, she has made remarkable strides in developing therapies for various cell proliferative diseases, including cancer.

Latest Patents

Among her latest innovations are the Anti-ErbB3 antibodies. These monoclonal antibodies are designed to bind and inhibit the activation of the epidermal growth factor receptor-related member ErbB3/HER3. The therapeutic potential of these antibodies lies in their ability to treat cell proliferative diseases and disorders, particularly certain forms of cancer associated with the activation of ErbB3/HER3.

Career Highlights

Throughout her career, Lyne has worked with notable companies such as Aveo Pharmaceuticals, Inc. and Xoma Technology Ltd. Her work in these organizations has been instrumental in advancing research and development in the field of cancer therapies.

Collaborations

Lyne has collaborated with esteemed colleagues, including William M Winston, Jr. and Jeno Gyuris, contributing to a rich exchange of ideas and innovations in her field.

Conclusion

Lyne Breault's innovative work and dedication to biotechnology have positioned her as a key figure in the development of new cancer therapies. Her contributions continue to impact the medical community and offer hope for patients facing challenging diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…